A daptomycin high-yield strain and its application
By constructing a CRP gene recombinant plasmid in Streptocytica Rospori, the tolerance to decanoic acid and the yield of daptomycin were improved, and the problems of low tolerance to decanoic acid and low yield of this strain were solved, achieving more High fermentation yield and higher capric acid utilization.
Patent Information
- Application Number
- CN202010456478.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-05-26
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2040-05-26
AI Technical Summary
Streptocytica rosporidium has low tolerance to capric acid and low yield of daptomycin, resulting in low fermentation yield, and insufficient genetic modification methods in the prior art.
By obtaining the CRP gene fragment, the recombinant plasmid pSET152CRP was constructed and introduced into Streptocytica Rospori to improve the strain's tolerance to capric acid and the yield of daptomycin.
The tolerance of Streptocytica Rospori to capric acid and the fermentation yield of daptomycin was significantly improved, achieving higher yields and higher capric acid utilization.
Smart Images

Figure CN113717909B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of genetic engineering, and in particular to a daptomycin high-yield strain and a preparation method thereof. Background Art
[0002] Daptomycin is a new type of cyclic lipopeptide antibiotic produced by Streptomyces roseosporus. It interacts with cell membranes in a calcium-dependent manner and exerts bactericidal activity. Daptomycin is a microbial secondary metabolite with a complex structure and very low yield. Genetic engineering is an important strategy to increase daptomycin production and reduce production costs.
[0003] Decanoic acid is an exogenous precursor in the synthesis of daptomycin, which can change the secondary metabolic direction of the bacteria. In the production of daptomycin, decanoic acid is an essential substance, but excessive decanoic acid will be toxic to Streptomyces roseosporus; on the contrary, if the concentration of decanoic acid is too low, it will lead to insufficient supply of precursors and reduce the potency of the product in the fermentation broth.
[0004] At present, the international daptomycin fermentation unit is close to 2g / L, while the overall domestic fermentation unit is far below this level. In response to the current situation of low fermentation yield, some relevant research has been carried out in China to increase its yield, but there are not many reports on targeted modification at the genetic level to increase daptomycin production. Summary of the invention
[0005] The purpose of the present invention is to provide a daptomycin strain with improved decanoic acid utilization and tolerance and a construction method thereof, so as to solve the technical problems of low tolerance of Streptomyces roseosporus to precursors and low daptomycin production in the prior art. The deposit number of the strain of the present invention is CGMCC No.18297.
[0006] The present invention also aims to provide a method for constructing a recombinant plasmid containing a regulatory gene.
[0007] The third object of the present invention is to provide the application of the plasmid in the genetic modification of daptomycin-producing bacteria.
[0008] As a specific embodiment, the recombinant strain is classified and named Streptomyces roseosporus ( Streptomyces roseosporus ), the deposit number of the recombinant strain is CGMCC No.18297.
[0009] The deposit information of the recombinant strain of the present invention is as follows:
[0010] Deposit date: July 26, 2019;
[0011] Name of depository: General Microbiology Center of China Microbiological Culture Collection Administration;
[0012] Deposit number: CGMCC No.18297;
[0013] Address of the depository: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing;
[0014] Classification name: Streptomyces roseosporus ( Streptomyces roseosporus ).
[0015] As a specific embodiment, the recombinant strain is a decanoic acid-tolerant strain.
[0016] As a specific embodiment, the capric acid tolerance of the recombinant strain is twice that of the starting strain.
[0017] As a specific embodiment, the recombinant strain is used in the fermentation production of daptomycin.
[0018] As a specific embodiment, the recombinant strain is used to improve the tolerance of Streptomyces roseosporus to decanoic acid, improve the utilization rate of decanoic acid and increase the fermentation yield of daptomycin.
[0019] The steps of increasing the yield of daptomycin provided by the present invention are as follows:
[0020] (1) The homologous sequence of CRP in Streptomyces roseosporus was obtained through the NCBI database, and a subcloned fragment of CRP was obtained from the genome of Streptomyces roseosporus. The subcloned fragment was cloned into a vector to obtain a recombinant plasmid containing the CRP gene fragment.
[0021] (2) The recombinant plasmid was introduced into Streptomyces roseosporus NO.CGMCC4.7231 by the Streptomyces conjugative transfer method, and the recombinant strain containing the CRP gene was obtained by antibiotic screening.
[0022] (3) Fermentation verification is carried out on the recombinant strain to obtain a high-yield strain.
[0023] As a specific implementation manner, the nucleotide sequence of the subcloned fragment in step (1) is shown as SEQ ID NO.1.
[0024] As a specific embodiment, the vector in step (1) contains an erme promoter.
[0025] As a specific implementation manner, the recombinant plasmid in step (1) is pSET152CRP.
[0026] The invention has the advantages of solving the problems of high workload and high blindness of traditional Streptomyces breeding by using the global regulatory factor CRP, obtaining a daptomycin high-yield strain cultivated by genetic engineering, and having broad application prospects; the method is used to transform the starting bacterium Streptomyces roseosporus, and the obtained recombinant strain can improve the tolerance and utilization rate of Streptomyces roseosporus to decanoic acid, and improve the yield of daptomycin. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 It is a comparison diagram of the fermentation yields of the high antibiotic yield Streptomyces roseosporus of the present invention and the existing Streptomyces roseosporus after normalization processing under different precursor concentrations in the culture medium;
[0028] Figure 2 is the physical map of pSET152CRP;
[0029] Figure 3 is int Φ C31 integration mode;
[0030] Figure 4 This is a comparison chart of the normalized daily daptomycin potency of the construction bacteria and the starting bacteria in the present invention during the fermentation process under two feeding processes: daily feeding of the amount of capric acid in the normal production process and daily feeding of twice the normal amount of capric acid;
[0031] Figure 5 This is a comparison chart of daily capric acid utilization (titer / cumulative amount of capric acid added) of the construction bacteria and the starting bacteria in the present invention during the fermentation process under two feeding processes: daily feeding of capric acid in the normal production process and daily feeding of capric acid twice the normal amount. DETAILED DESCRIPTION
[0032] The present invention is described in detail below by way of examples.
[0033] In the present invention, unless otherwise specified, all equipment and raw materials can be purchased from the market or are commonly used in the industry. The methods in the following embodiments, unless otherwise specified, are conventional methods in the art.
[0034] Example 1: Construction of recombinant plasmid pSET152CRP containing CRP gene:
[0035] The nucleotide sequence of the homologous gene CRP reported in Streptomyces coelicolor was blasted with the genome sequence of Streptomyces roseosporus from NCBI (website: www.ncbi.nlm.nih.gov) to obtain the target gene CRP in Streptomyces roseosporus, which has a size of 672 bp.
[0036] Primers were designed using Primer 5.0 as follows:
[0037] CRPS:ATTTCTAGAAATACCTGACCGAGCACG;
[0038] CRPA:ATTGGATCCATCGCACTGTTTTACCGT.
[0039] The total DNA of Streptomyces roseosporus was extracted, the CRP gene was amplified, and the target gene fragment was obtained.
[0040] The pSET152 plasmid was extracted using the SanPerp column plasmid DNA small-scale extraction kit according to the kit instructions. The obtained plasmid DNA solution was stored at -20°C or used for subsequent experiments.
[0041] Treat the pSET152 plasmid with restriction endonucleases, perform DNA agarose gel electrophoresis after enzyme digestion, use the SanPerp column DNA gel recovery kit according to the instructions to recover a fragment of 858 bp in size and store the resulting DNA solution at -20°C or use it in subsequent experiments.
[0042] The amplified CRP gene was connected with the pSET152 plasmid fragment recovered after restriction digestion. The restriction digestion and ligation reaction system: 0.03 pmol of vector, 0.03-0.3 pmol of fragment, 1200 U of T4 DNA ligase, 5 ul of buffer, and the remaining volume was supplemented with distilled water. The connection was carried out at 16°C for 16 hours to obtain a ligation product.
[0043] Take 200ul of competent E. coli cells, add the above-mentioned ligation product, gently rotate to mix the contents, and place in ice for 30min. Place the tube in a circulating water bath preheated to 42°C for 90s. Quickly transfer the tube to a water bath and cool the cells for 1-2min. Add 800ul of LB medium preheated at 37°C to each tube, and then transfer to a 37°C water bath for 45min. Transfer an appropriate volume of transformed competent cells to LB medium containing the corresponding resistance. Colonies will appear after inverted culture at 37°C for 12-16h. Pick colonies for enzyme digestion verification, and take the verified colonies for preservation and sequencing verification.
[0044] The recombinant plasmid pSET152CRP is 7033 bp in size, carries an Ampola resistance gene, can be screened in Escherichia coli and Streptomyces roseosporus, int Φ C31 is an integrase gene, attP is an integration site, and p*erme is an erythromycin promoter.
[0045] LB medium formula: 10g tryptone, 10g yeast extract, 10g NaCl, add deionized water to 1000ml, pH 7.0. Sterilize at 121℃ for 30min, used to culture Escherichia coli. Add 2% agar powder to the solid medium.
[0046] Example 2: Transfer of the recombinant plasmid to Streptomyces roseosporus by intergeneric conjugation
[0047] Escherichia coli ET12567 containing the recombinant plasmid PSET152CRP was conjugated with Streptomyces roseosporus NO.CGMCC4.7231, and the conjugates containing the PSET152CRP plasmid were screened with apramycin and nalidixic acid. At the same time, the vector introduced with the empty vector PSET152 was used as a control.
[0048] The indirect transfer method between Escherichia coli and Streptomyces roseosporus NO.CGMCC4.7231:
[0049] Inoculate ET12567 (PUZ8002 / PSET152) and ET12567 (PUZ8002 / PSET152CRP) into LB (containing kanamycin / chloramphenicol / ampicillin) medium and culture overnight in a shaker at 37℃ and 220rpm. Transfer ET12567 (PUZ8002 / PSET152) and ET12567 (PUZ8002 / PSET152CRP) into fresh LB medium (containing kanamycin / chloramphenicol / ampicillin) at a ratio of 1:100, and culture in a shaker at 37℃ and 220rpm until OD600 reaches 0.3-0.4. Resuspend the cells twice with the same volume of LB medium, and finally resuspend in 0.1 times the volume of LB medium. While washing the cells, suspend 10-8 spores required for each conjugation transfer in 500ul 2×YT medium, heat shock at 50℃ for 10min, and cool to room temperature. Take 500ul of Escherichia coli liquid and Streptomyces roseosporus spore liquid respectively, mix thoroughly, centrifuge to remove most of the supernatant, and resuspend with the remaining liquid. Spread the mixed bacterial liquid on MS solid medium containing 10mM MgCl2 and culture at 29°C for 16-20h. Take 1ml of sterile water containing 0.5mg nalidixic acid and 1mg apramycin, and evenly cover it on the plate for conjugation transfer. Continue to culture in a 29°C incubator for 2-3 days, and the conjugant can be observed. Use the streaking method to obtain a single colony of Streptomyces roseosporus containing PSET152CRP, and inoculate the single colony into a 5ml TSB liquid test tube containing 75ug nalidixic acid and 250ug apramycin for passage to verify the genotype of the conjugant.
[0050] 2×YT medium formula:
[0051] Tryptone 16g, yeast extract 10g, NaCl 5g, add deionized water to 1000ml, adjust the pH to 7.0 with 5N NaOH, and sterilize with high pressure steam at 121℃ for 20min.
[0052] MS medium formula:
[0053] Mannitol 20g, soybean cake powder 20g, agar 20g, add deionized water to 1000ml, pH 7.2-7.3, sterilize twice at 115℃, 15min, add 1M MgCl2 to a final concentration of 10mM / L when using. (1M MgCl2: MgCl2.7H2O)
[0054] Example 3: Recombinant bacteria fermentation process
[0055] After the constructed Streptomyces roseosporus strain was cultured in R5 slant medium at 30℃ for 5 days, it was transferred to a shake flask containing 50ml YEME liquid medium and cultured at 30℃ with shaking (220rpm / min) for 25h. During the fermentation, decanoic acid was used as a fermentation precursor. The fermentation was completed and the strain with the highest yield was selected. Figure 1 As shown, compared with the existing Streptomyces roseosporus (starting bacteria), the high antibiotic yield Streptomyces roseosporus prepared in the present invention has a higher fermentation yield, that is, a better daptomycin yield, and the fermentation yield is increased by more than 200%.
[0056] TSB liquid medium formula:
[0057] 17 g of tryptic peptone, 3 g of soy peptone, 2.5 g of D-glucose, 5 g of sodium chloride, 2.5 g of dipotassium hydrogen phosphate, add deionized water to 1000 ml, and sterilize at 121°C for 30 min.
[0058] R5 medium formula:
[0059] Sucrose 103.0g, K2SO4 0.25g, MgCl2·6H20 10.12g, glucose 10.0g, hydrolyzed casein 0.1g, trace element solution 2.0g, yeast extract 5.0g, TES buffer 57.3ml, KH2PO4 (0.5%) 10ml, CaCl2·H2O (5M) 4ml, L-proline (20%) 150ml, NaOH (1N) 7ml, agar 20.0g, add deionized water to 1000ml, pH 7.2. Sterilize at 115℃ for 30min.
[0060] Trace element solution (per liter): ZnCl2 40 mg, FeCl2·6H2O 200 mg, CuCl2·2H2O 10 mg, MnCl2·2H2O 10 mg, Na2B4O7·10H2O 10 mg, (NH4)6Mo7O 24 4H2O 10mg
[0061] YEME medium formula:
[0062] Yeast extract 1.5g, tryptone 5g, malt extract 3g, glucose 10g, sucrose 250g, add deionized water to 1000ml, and steam sterilize at 115℃ for 15min.
[0063] Example 4: HPLC determination of daptomycin fermentation units:
[0064] Chromatographic conditions: chromatographic column: Phenomenex IB-SIL C8 4.6×250mm 5um, flow rate: 1.0ml / min, detection wavelength: 223nm, injection volume: 25ul, column temperature: 25℃, gradient elution mobile phase A: weigh 3.4g of ammonium dihydrogen phosphate and dissolve it in 1000ml of distilled water, adjust the pH to 3.1 with phosphoric acid, mobile phase B: acetonitrile.
[0065] Example 5: Constructing strains to test tolerance to precursor concentrations
[0066] The fermentation process of Example 3 was used to compare the tolerance range of the starting strain NO.CGMCC4.7231 and the constructed strain to the concentration of the fermentation precursor in the culture medium in a shake flask. The experimental results are shown in the attached manual. Figure 1 As shown, the production of daptomycin in the shake flask was the highest when the precursor concentration of the constructed bacteria was 3% to 5%, and the production dropped significantly after exceeding 5%; however, the precursor concentration with the highest production of the starting bacteria was 2% to 3%, and the production dropped significantly after 3%. This indicates that the CRP gene can improve the tolerance of Streptomyces roseosporus to the precursors in the culture medium, and in industrial production, the amount of decanoic acid added in the fermentation tank can be increased to obtain a higher yield per unit volume.
[0067] Example 6: Comparison of pilot fermentation processes with different starting and construction strains
[0068] According to the pilot fermentation process of daptomycin, the constructed Streptomyces roseosporus strain was cultured in a seed tank for 22-26 hours, then transferred to a fermentation tank and cultured at about 30°C for 25 hours. During the fermentation, capric acid was continuously fed as a fermentation precursor. According to the tolerance of the constructed bacteria to the precursor, the amount of capric acid added to the tank was twice that of the normal process of the starting bacteria. For comparison, the starting bacteria tried to use the same feeding process as the constructed bacteria (i.e., the amount of capric acid added was twice that of the original process). The culture was cultured until the end of the fermentation, and the fermentation units were determined by HPLC for comparison.
[0069] Seed tank formula: potato starch 6%, glucose 1.5%, sugarcane molasses 0.72%, ferrous ammonium sulfate 0.08%, bubo 0.05%.
[0070] Fermentation tank formula: potato starch 7.2%, glucose 1%, cane molasses 0.72%, yeast powder 1.2%, ammonium ferrous sulfate 0.086%, and dapoxetine 0.05%.
[0071] The experimental results are as shown in the attached manual. Figure 5 As shown in the figure, on the 7th and 8th day of fermentation in the tank, the titer of the constructed bacteria was 2.5-3 times that of the original process of the starting bacteria, and more than twice that of the same process of the starting bacteria (i.e., the amount of decanoic acid added was twice that of the original process). The results showed that during the fermentation process, the utilization rate of decanoic acid of the constructed bacteria (calculated as titer / cumulative amount of decanoic acid added) was more than twice that of the original process of the starting bacteria, and was also significantly improved compared with the same process of the starting bacteria (i.e., the amount of decanoic acid added was twice that of the original process). The above two figures show that, firstly, the constructed bacteria significantly increased the expression of daptomycin in the tank and increased the yield of a single fermentation; secondly, the constructed bacteria significantly increased the utilization rate of decanoic acid, so that more daptomycin was produced after adding the same amount of decanoic acid.
[0072] It should be understood that those skilled in the art can make improvements or changes based on the above description, and all these improvements and changes should fall within the scope of protection of the appended claims of the present invention. SEQUENCELISTING <110> Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Zhejiang University of Technology <120> A daptomycin high-yield strain and its application <130> 1 <160> 1 <170> PatentInversion3.5 <210> 1 <211> 672 <212> DNA <213> Streptomyces roseosporus <400> 1 gcgcgagcgcttcgccagccgctcgacgtccagcaggatgaccgcccgggcctccagccg60 cagccagccgcggcccgcgaagtccgcgagggccttgttgaccgtctcgcgggaagcgcc120 gaccagctgggccagctcctcctgggtgaggtcgtgcacgacgtggatgccttcctcgga180 ctggacgccgaagcggcgcgacaggtccaggagggcgcgggcgacacggcccggcacgtc240 ggagaagaccaggtcggacatctggtcgttggtcttgcgcagccgtcgggcgaccgcgcg300 cagcagcgcggtggccacctcgggccgggcgttcagccagggctgcaggtcgccgtggcc360 gaggccgaggagcttgacctcggtcagtgcggaggcggtcgccgtacgcgggcccgggtc420 gaagagcgacagctccccgatcagctcgccggggccgagcacggccagcatgttctcgcg480 cccgtcgggcgaggtgcggtggagcttcaccttgccctcggtgaccacgtacaggcggtc540 accctggtcgccctcgtggaacagcgcgtctccgcgcgcgagggtcacctcactcatcga600 ggcgcggagctccgcggcctgctcgtcatcgagcgccgcgaaaagcggggcgcgccgcag660 aacgtcgtccac672
Claims
1. A recombinant strain with high daptomycin production, characterized in that: The recombinant strain was named Streptomyces roseosporus ( Streptomyces roseosporus ), the deposit number of the recombinant strain is CGMCC NO.18297.
2. The recombinant strain with high daptomycin production according to claim 1, characterized in that: The recombinant strain is a decanoic acid tolerant strain.
3. Use of the recombinant strain according to any one of claims 1 to 2 in the fermentation production of daptomycin.
